MYROBALAN THERAPEUTICS
Live / Allowed — Fourth extension granted (statement of use) (as of 03 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 Nov 2021 filing date already counts against anyone who files later.
Record
- Serial number
- 97111174
- Mark type
- Design + words
- Filed
- 05 Nov 2021
- Published for opposition
- 09 Jan 2024
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of neurodegenerative diseases, demyelination diseases, schizophrenia spectrum disorders, neuropathic pain, neuroinflammation diseases, neuroexcitation disorders, immunological disorders and cancers, the pharmaceutical preparations are not derived from or containing a component of the myrobalan tree
- Class 042 — Scientific and technological services: research and development of pharmaceutical preparations not derived from or containing a component of the myrobalan tree
Owner
- Myro Therapeutics, Arlington, MA, KY
- Myro Therapeutics, Arlington, MA, KY
Prosecution history
- 25 Sept 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2026 — SOU EXTENSION 4 GRANTED
- 03 Feb 2026 — SOU EXTENSION 4 FILED
- 03 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2025 — SOU EXTENSION 3 GRANTED
- 02 Jul 2025 — SOU EXTENSION 3 FILED
- 02 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2025 — SOU EXTENSION 2 GRANTED